Flying The Web For News.
  • Career Exam Study
    Career Exam Study
  • 2024 Presidential Election
    2024 Presidential Election
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News
+ Larger Font | - Smaller Font
Share

Globe NewsWire News Distribution Service

Press Release: Cellectar Biosciences to Highlight 2025 Strategic Initiatives at Upcoming Biotech Showcase during the JP Morgan Healthcare Conference

Details
Category: Globe NewsWire News Distribution Service

Oral Presentation Presented at ASH 2024 Showed Iopofosine I 131 Achieved an 83.6% ORR and Exceeded Primary and Secondary Efficacy Endpoints in Phase 2 CLOVER-WaM Study for Relapsed/Refractory Waldenstrom’s Macroglobulinemia


Posted: 2025-01-12 23:00:00

Get Full News Story On GlobeNewsWire Press Release Service



Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.

Tags

press | release | cellectar | biosciences | highlight


Related News Stories From The Web And More

Related Bing News Search Results

Press Release: Cellectar Biosciences to Highlight 2025 Strategic Initiatives at Upcoming Biotech Showcase during the JP Morgan Healthcare Conference - Newscast

Cellectar Biosciences Inc (CLRB) Stock Dive: The Hidden Causes Revealed

Wed, 05 Feb 2025 05:26:00 GMT Cellectar Biosciences Inc’s profitability metrics reveal financial health. The company currently boasts a gross margin of -86.87%. The profit margin, also known as the revenue ratio or gross profit ...

Cellectar faces Nasdaq delisting over share price rule

Sun, 02 Feb 2025 17:56:00 GMT Cellectar Biosciences Inc. (NASDAQ:CLRB), a pharmaceutical company with a market capitalization of $10.38 million, has been notified by Nasdaq that it is not in compliance with the minimum bid price ...

Cellectar Biosciences to Highlight 2025 Strategic Initiatives at Upcoming Biotech Showcase during the JP Morgan Healthcare Conference

Sun, 12 Jan 2025 15:09:00 GMT About Cellectar Biosciences, Inc. Cellectar Biosciences ... Forward-Looking Statement Disclaimer This news release contains forward-looking statements. You can identify these statements by our ...

Cellectar Biosciences to Highlight 2025 Strategic Initiatives at Upcoming Biotech Showcase during the JP Morgan Healthcare Conference

Sun, 12 Jan 2025 15:00:00 GMT About Cellectar Biosciences, Inc. Cellectar Biosciences is a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of proprietary drugs for the ...

Cellectar Biosciences to Highlight 2025 Strategic Initiatives at Upcoming Biotech Showcase during the JP Morgan Healthcare Conference

Sun, 12 Jan 2025 15:00:00 GMT About Cellectar Biosciences, Inc. Cellectar Biosciences is a late-stage ... LinkedIn, and Facebook. This news release contains forward-looking statements. You can identify these statements by our use ...


Blow Us A Whistle